Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Alzheimer’s disease

Neurona secures $120m to advance lead cell therapy candidate for epilepsy

NRTX-1001 is being assessed for drug-resistant mesial temporal lobe epilepsy

February 16, 2024 Alzheimer's disease, focal epilepsy, mesial temporal lobe epilepsy, Neurona, News, NRTX-1001

Disrupted sleep could be associated with cognitive function changes

High amounts of disrupted sleep were found to affect memory and thinking performance

January 4, 2024 Alzheimer's disease, cognitive function, Dementia, neurodegenerative disorders, News, University of California

Posts navigation

Posts pagination

« Previous 1 2
Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy